J076-0199 Screening compound: N-[(3-methoxyphenyl)methyl]-4-{3-[(4-methylphenyl)methyl]-2-oxo-1,3-diazinan-1-yl}benzamide

J076-0199 Screening compound: N-[(3-methoxyphenyl)methyl]-4-{3-[(4-methylphenyl)methyl]-2-oxo-1,3-diazinan-1-yl}benzamide
J076-0199 Screening compound: N-[(3-methoxyphenyl)methyl]-4-{3-[(4-methylphenyl)methyl]-2-oxo-1,3-diazinan-1-yl}benzamide alternative view

Chemical Structure Depiction of ChemDiv screening compound J076-0199
N-[(3-methoxyphenyl)methyl]-4-{3-[(4-methylphenyl)methyl]-2-oxo-1,3-diazinan-1-yl}benzamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

J076-0199

Molecular Formula

C27H29N3O3 (C27 H29 N3 O3)

Compound Name

N-[(3-methoxyphenyl)methyl]-4-{3-[(4-methylphenyl)methyl]-2-oxo-1,3-diazinan-1-yl}benzamide

IUPAC name

N-[(3-methoxyphenyl)methyl]-4-{3-[(4-methylphenyl)methyl]-2-oxo-13-diazinan-1-yl}benzamide

SMILES

Cc1ccc(CN(CCCN2c(cc3)ccc3C(NCc3cc(OC)ccc3)=O)C2=O)cc1

InChI

InChI=1S/C27H29N3O3/c1-20-7-9-21(10-8-20)19-29-15-4-16-30(27(29)32)24-13-11-23(12-14-24)26(31)28-18-22-5-3-6-25(17-22)33-2/h3,5-14,17H,4,15-16,18-19H2,1-2H3,(H,28,31)

InChI Key

UMDGHNOYWQYPFR-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27223592

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

443.55

Hydrogen Bond Acceptors Count

5.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

8.00

Number of Nitrogen and Oxygen Atoms

6

Partition Coefficient, logP

4.435

Distribution Coefficient, logD

4.435

Water Solubility, LogSw

-4.29

Polar Surface Area

51.754

Acid Dissociation Constant (pKa)

12.00

Base Dissociation Constant (pKb)

-0.67

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

25.90

J076-0199 in Drug Discovery

Included in Screening Libraries

Protein Tyrosine Phosphatase Non-receptor Type (PTPN) Targeted Library (32556 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Nervous system
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Endocrine
Targets:
  • Phosphatases

References: we are preparing a list of scientific research reports with J076-0199 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound J076-0199?
Check Price and Availability of J076-0199, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of J076-0199 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for J076-0199
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for J076-0199
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of J076-0199 available by request